Effects of Chlamydia trachomatis infection on the expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis

被引:31
|
作者
Hook, CE
Telyatnikova, N
Goodall, JC
Braud, VM
Carmichael, AJ
Wills, MR
Gaston, JSH
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
[2] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2004年 / 138卷 / 01期
关键词
bacterial infection; human; NK cells;
D O I
10.1111/j.1365-2249.2004.02596.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) cells are an important component of the immediate immune response to infections, including infection by intracellular bacteria. We have investigated recognition of Chlamydia trachomatis (CT) by NK cells and show that these cells are activated to produce interferon (IFN)-gamma when peripheral blood mononuclear cells (PBMC) are stimulated with CT organisms. Furthermore, infection of epithelial cell lines with CT renders them susceptible to lysis by human NK cells. Susceptibility was observed 18-24 h following infection and required protein synthesis by the infecting chlamydiae, but not by the host cell; heat or UV inactivated chlamydiae did not induce susceptibility to NK cell lysis. CT infection was also shown to decrease the expression of classical and non-classical major histocompatibility complex (MHC) molecules on infected cells, thus allowing recognition by NK cells when combined with an activating signal. A candidate activating signal is MICA/B, which was shown to be expressed constitutively on epithelial cells.
引用
收藏
页码:54 / 60
页数:7
相关论文
共 50 条
  • [31] In vivo natural killer (NK) cell function and development revealed by mice with selective NK cell-deficiency.
    Yokoyama, WM
    Iizuka, K
    Chu, D
    Kim, S
    JOURNAL OF LEUKOCYTE BIOLOGY, 2000, : 21 - 21
  • [32] Does hyperthermia increase the susceptibility of liposarcoma cells to NK cell lysis?
    Farjadian, Shirin
    Rahimifar, Shahrzad
    Hosaini-Nasab, Fahimeh
    Erfani, Nasrolah
    Ghaderi, Abbas
    Lotfi, Ramin
    TISSUE ANTIGENS, 2010, 75 (05): : 633 - 634
  • [33] Tetrabromobisphenol A decreases cell-surface proteins involved in human natural killer (NK) cell-dependent target cell lysis
    Hurd, Tasia
    Whalen, Margaret M.
    JOURNAL OF IMMUNOTOXICOLOGY, 2011, 8 (03) : 219 - 227
  • [34] Natural killer (Nk) cell crossmatch: Functional analysis of inhibitory KIR receptors and their HLA ligands
    Fallena, M
    Han, M
    Stastny, P
    HUMAN IMMUNOLOGY, 2004, 65 : S16 - S16
  • [35] NATURAL-KILLER (NK) CELL-MEDIATED LYSIS IN RELATION TO TARGET-CELL DIFFERENTIATION - STUDIES AT THE SINGLE CELL LEVEL
    HAGNER, G
    CELL AND TISSUE KINETICS, 1984, 17 (03): : 293 - 293
  • [36] Expression of MICA/b, a ligand for natural killer (NK) cell recognition, on human pancreatic adenocarcinoma and potential for NK intervention
    Djeu, Julie
    Gilvary, Danielle
    Thu Le Trinh
    Nhan Tu
    Coppola, Domenico
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [37] MODIFICATION OF TARGET-CELL SUSCEPTIBILITY TO MURINE AND HUMAN NK-CELL LYSIS
    AXBERG, I
    WIGZELL, H
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1982, 16 (05) : 446 - 446
  • [38] Decreased natural killer (NK) cell function in chronic NK cell lymphocytosis associated with decreased surface expression of CD11b
    Orange, JS
    Chehimi, J
    Ghavimi, D
    Campbell, D
    Sullivan, KE
    CLINICAL IMMUNOLOGY, 2001, 99 (01) : 53 - 64
  • [39] DECREASED MHC CLASS-I EXPRESSION ON HUMAN FIBROBLASTS FOLLOWING INFECTION WITH HSV-1 FAILS TO CORRELATE WITH SUSCEPTIBILITY TO NATURAL-KILLER (NK) CELL-MEDIATED LYSIS
    LI, QH
    PETTERA, L
    STEIN, D
    GARCIA, Z
    FITZGERALDBOCARSLY, P
    FASEB JOURNAL, 1992, 6 (05): : A2052 - A2052
  • [40] Impairment of natural killer cell activity in Chlamydia trachomatis infected individuals
    Mavoungou, E
    Poaty-Mavoungou, V
    Touré, FS
    Sall, A
    Delicat, A
    Yaba, P
    Mandeme, Y
    Nabias, R
    Lansoud-Soukate, J
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1999, 4 (11) : 719 - 727